2025-03-28 18:50:39
Latest Post
Maithan A1loys Limited purchases 1.99 lakh shares of NSE
Lancor Holdings Ltd updates on new projects
Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
Aerolloy Technologies secures major order from Safran Aircraft Engines for LEAP Engine Cast Components
Stock Report
Medinova Diagnostic Services Ltd posts consolidated Q4FY24 PAT of Rs. 59.89 lakhs
Posted On : 2024-04-27 09:56:11( TIMEZONE : IST )
MEDINOVA DIAGNOSTIC SERVICES LTD. has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 2.6235 crores during the period ended March 31, 2024 as compared to Rs. 2.4190 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 0.5989 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 0.4028 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.60 for the period ended March 31, 2024 as compared to Rs. 0.40 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 2.6235 crs | ₹2.4190 crs |  8.45% |
| Net Profit | ₹0.5989 crs | ₹0.4028 crs | 48.68% |
| EPS | ₹0.60 | ₹0.40 | 50.00% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 2.6235 crores during the period ended March 31, 2024 as compared to Rs.2.9143 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.5989 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.0.7729 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.60 for the period ended March 31, 2024 as compared to Rs.0.78 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 2.6235 crs | ₹2.9143 crs |  -9.98% |
| Net Profit | ₹0.5989 crs | ₹0.7729 crs | -22.51% |
| EPS | ₹0.60 | ₹0.78 | -23.08% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.10.3634 crores during the Financial Year ended March 31, 2024 as compared to Rs.10.2181 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.1.9989 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.1.6652 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.2 for the Financial Year ended March 31, 2024 as compared to Rs.1.67 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹10.3634 crs | ₹10.2181 crs | 1.42% |
| Net Profit | ₹1.9989 crs | ₹1.6652 crs | 20.04% |
| EPS | ₹2 | ₹1.67 | 19.76% |
Shares of MEDINOVA DIAGNOSTIC SERVICES LTD. was last trading in BSE at Rs. 39.56 as compared to the previous close of Rs. 37.68. The total number of shares traded during the day was 6573 in over 70 trades.
The stock hit an intraday high of Rs. 39.56 and intraday low of 39.50. The net turnover during the day was Rs. 260021.00.
